The Role of Oxidative Stress in Atherosclerosis
- PMID: 36497101
- PMCID: PMC9735601
- DOI: 10.3390/cells11233843
The Role of Oxidative Stress in Atherosclerosis
Abstract
Atherosclerosis is a chronic inflammatory disease of the vascular system and is the leading cause of cardiovascular diseases worldwide. Excessive generation of reactive oxygen species (ROS) leads to a state of oxidative stress which is a major risk factor for the development and progression of atherosclerosis. ROS are important for maintaining vascular health through their potent signalling properties. However, ROS also activate pro-atherogenic processes such as inflammation, endothelial dysfunction and altered lipid metabolism. As such, considerable efforts have been made to identify and characterise sources of oxidative stress in blood vessels. Major enzymatic sources of vascular ROS include NADPH oxidases, xanthine oxidase, nitric oxide synthases and mitochondrial electron transport chains. The production of ROS is balanced by ROS-scavenging antioxidant systems which may become dysfunctional in disease, contributing to oxidative stress. Changes in the expression and function of ROS sources and antioxidants have been observed in human atherosclerosis while in vitro and in vivo animal models have provided mechanistic insight into their functions. There is considerable interest in utilising antioxidant molecules to balance vascular oxidative stress, yet clinical trials are yet to demonstrate any atheroprotective effects of these molecules. Here we will review the contribution of ROS and oxidative stress to atherosclerosis and will discuss potential strategies to ameliorate these aspects of the disease.
Keywords: atherosclerosis; mitochondria; oxidative stress.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Targeting NADPH oxidases in vascular pharmacology.Vascul Pharmacol. 2012 May-Jun;56(5-6):216-31. doi: 10.1016/j.vph.2012.02.012. Epub 2012 Mar 3. Vascul Pharmacol. 2012. PMID: 22405985 Free PMC article. Review.
-
Pharmacological strategies to lower crosstalk between nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and mitochondria.Biomed Pharmacother. 2019 Mar;111:1478-1498. doi: 10.1016/j.biopha.2018.11.128. Epub 2019 Feb 14. Biomed Pharmacother. 2019. PMID: 30841463 Review.
-
Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis.Circ Res. 2017 Feb 17;120(4):713-735. doi: 10.1161/CIRCRESAHA.116.309326. Circ Res. 2017. PMID: 28209797 Review.
-
Nitric oxide and oxidative stress in vascular disease.Pflugers Arch. 2010 May;459(6):923-39. doi: 10.1007/s00424-010-0808-2. Epub 2010 Mar 21. Pflugers Arch. 2010. PMID: 20306272 Review.
-
Vascular oxidative stress, nitric oxide and atherosclerosis.Atherosclerosis. 2014 Nov;237(1):208-19. doi: 10.1016/j.atherosclerosis.2014.09.001. Epub 2014 Sep 9. Atherosclerosis. 2014. PMID: 25244505 Review.
Cited by
-
Antioxidant Activity of Planar Catechin Conjugated with Trolox.Antioxidants (Basel). 2024 Sep 25;13(10):1165. doi: 10.3390/antiox13101165. Antioxidants (Basel). 2024. PMID: 39456420 Free PMC article.
-
Preparation, Evaluation, and Bioinformatics Study of Hyaluronic Acid-Modified Ginsenoside Rb1 Self-Assembled Nanoparticles for Treating Cardiovascular Diseases.Molecules. 2024 Sep 18;29(18):4425. doi: 10.3390/molecules29184425. Molecules. 2024. PMID: 39339421 Free PMC article.
-
Associations between the New DNA-Methylation-Based Telomere Length Estimator, the Mediterranean Diet and Genetics in a Spanish Population at High Cardiovascular Risk.Antioxidants (Basel). 2023 Nov 15;12(11):2004. doi: 10.3390/antiox12112004. Antioxidants (Basel). 2023. PMID: 38001857 Free PMC article.
-
Inhibition of Endothelial Inflammatory Response by HT-C6, a Hydroxytyrosol Alkyl Ether Derivative.Antioxidants (Basel). 2023 Jul 28;12(8):1513. doi: 10.3390/antiox12081513. Antioxidants (Basel). 2023. PMID: 37627508 Free PMC article.
-
Comparison of the protective effects of chitosan oligosaccharides and chitin oligosaccharide on apoptosis, inflammation and oxidative stress.Exp Ther Med. 2024 Jun 5;28(2):310. doi: 10.3892/etm.2024.12600. eCollection 2024 Aug. Exp Ther Med. 2024. PMID: 38873041 Free PMC article.
References
-
- World Health Organisation, World Health Organisation Cardiovascular Disease Fact Sheet. 2021. [(accessed on 10 November 2022)]. Available online: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-disea...
-
- Roth G.A., Mensah G.A., Johnson C.O., Addolorato G., Ammirati E., Baddour L.M., Barengo N.C., Beaton A.Z., Benjamin E.J., Benziger C.P., et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J. Am. Coll. Cardiol. 2020;76:2982–3021. doi: 10.1016/j.jacc.2020.11.010. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials